Patents
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
04/2012
04/25/2012CN102423297A 一种自微乳液及其制备方法 A self-microemulsion and its preparation method
04/25/2012CN102423295A 一种含有长春西汀的小容量注射液组合物及其制备方法 A vinpocetine small volume injection containing composition and its preparation method
04/25/2012CN102423294A Thermo sensitive in situ gel loaded with drug by chemical bonds, and preparation method thereof
04/25/2012CN102423293A 一种硝酸奥昔康唑的微乳凝胶制剂 One kind of nitrate oxiconazole microemulsion gel formulation
04/25/2012CN102068454B 一种预防瘤胃酸中毒的缓释调控剂及其制备方法 A method of preventing ruminal acidosis sustained-release regulation and its preparation method
04/25/2012CN102051016B 可降解的双亲性三嵌段共聚物胶束及其制备方法和用途 Biodegradable amphiphilic triblock copolymer micelles and their preparation and use
04/25/2012CN102018684B 一种坎地沙坦酯自微乳化软胶囊及其制备方法 One kind of candesartan cilexetil since microemulsifying soft capsule and its preparation method
04/25/2012CN101961335B 一种含恩诺沙星六水合物组合物及其在制备治疗或预防家禽疾病的药物中的应用 And its application in the manufacture of a medicament for treating or preventing disease in poultry in the composition containing enrofloxacin hexahydrate
04/25/2012CN101896595B 杀菌清洗剂组合物 Germicidal detergent composition
04/25/2012CN101829064B 右旋布洛芬颗粒及其制备方法 Dexibuprofen particle and its preparation method
04/25/2012CN101816644B 一种紫杉醇与苯丙氨酸的组合物及其制备方法 One of paclitaxel and phenylalanine composition and preparation method
04/25/2012CN101810563B 他克莫司眼用在体凝胶制剂及其制备方法 Tacrolimus ophthalmic gel formulations used in the body and its preparation method
04/25/2012CN101804177B Anti-depressive traditional Chinese medicinal composition and dripping pill
04/25/2012CN101780031B 一种用于修复皮肤创面或宫颈粘膜的诱导凝胶 A method for repairing skin wounds or cervical mucosa induced gelation
04/25/2012CN101773482B 一种三段式脉冲释药控释片及其制备方法 One kind of three-pulse release GITS its preparation method
04/25/2012CN101732724B 一种携载抗肿瘤药物的复合胶束及其制备方法 One kind of carrying antineoplastic complex micelles and its preparation method
04/25/2012CN101732247B 一种含有依达拉奉的注射液 Containing edaravone injection
04/25/2012CN101698692B 一种腰部交联双亲性纳米胶束及其制备方法 One kind of waist crosslinked amphiphilic micelles and its preparation method
04/25/2012CN101684174B 两亲性可生物降解聚酯梳型接枝共聚物及其温敏原位凝胶体系 Amphiphilic comb-shaped biodegradable polyester graft copolymer and its temperature-sensitive in situ gel system
04/25/2012CN101548946B 姜黄素纳米脂质注射液、其制备方法及用途 Curcumin Nanoliposomal injection, their preparation and use
04/25/2012CN101491575B 一种用于治疗异位性皮炎的中药提取物及其颗粒剂 A Chinese medicine for the treatment of atopic dermatitis extracts and granules
04/25/2012CN101217947B 包含壳聚糖和环糊精的纳米颗粒 Nanoparticles comprising chitosan and cyclodextrin
04/25/2012CN101199560B Ginkgo leaf extract and preparing method thereof
04/25/2012CN101181548B 一种含有天然抗菌剂的药用或保健组合物 Pharmaceutical or health care composition containing a natural antimicrobial agent
04/25/2012CN101069744B 流感疫苗组合物 Influenza vaccine composition
04/25/2012CN101040933B 维生素e的复合胶囊 Complex vitamin e capsules
04/24/2012US8163889 Physiologically active polypeptide conjugate having prolonged in vivo half-life
04/24/2012US8163307 Controlled release compositions for interferon based PEGT/PBT block copolymers and method for preparation thereof
04/24/2012US8163305 Targeted cross-linked nanoparticles and their use in vivo gene delivery
04/24/2012US8163298 Aqueous gel having an alpha-hydroxy acid and suspended particulates
04/24/2012US8163296 Dimensional analysis of saccharide conjugates with GPC and SEC-MALS
04/24/2012CA2671383C Dried composition
04/24/2012CA2666437C Method of preparation of a soluble formulation of water-insoluble pentacyclic and tetracyclic terpenoids, a soluble formulation of a pentacyclic or tetracyclic terpenoid and a pharmaceutical composition containing this soluble formulation
04/24/2012CA2645467C Pyridine derivative having anti-helicobacter pylori activity
04/24/2012CA2542834C Conjugates or co-administration of igf-1 receptor ligands with anti-cancer chemotherapeutic agents
04/24/2012CA2539256C Targeted lipid-drug formulations for delivery of drugs to myeloid and lymphoid immune cells
04/24/2012CA2534259C Glycyrrhizin high-concentration preparation
04/24/2012CA2472582C Sterile filtered nanoparticulate formulations of budesonide and beclomethasone having tyloxapol as a surface stabilizer
04/24/2012CA2471418C Method of obtaining novel lutein-based formulations
04/24/2012CA2466244C Methods and apparatus for production of a micro-organ
04/24/2012CA2466116C Synthetic matrix for controlled cell ingrowth and tissue regeneration
04/24/2012CA2466036C Taste masking spill-resistant formulation
04/24/2012CA2465132C Vaginally administered anti-dysrhythmic agents for treating pelvic pain
04/24/2012CA2447376C Prebiotic and probiotic compositions and methods for their use in gut-based therapies
04/24/2012CA2439570C In-situ gel formation of pectins
04/24/2012CA2408752C Delivery systems for treatment of vascular disease
04/24/2012CA2277141C Process for preparing conjugate vaccines including free protein and the conjugate vaccines, immunogens, and immunogenic reagents produced by this procedure
04/22/2012CA2745270A1 System and method for satellite drug delivery
04/19/2012WO2012051614A2 Delivery of hydrophobic bioactive agents
04/19/2012WO2012051488A1 Pharmaceutical compositions containing a dgat1 inhibitor
04/19/2012WO2012051447A1 Targeted delivery of targeted exocytosis modulators to the sphenopalatine ganglion for treatment of headache disorders
04/19/2012WO2012051416A1 Pharmaceutical formulation for histone deacetylase inhibitors
04/19/2012WO2012051204A2 Antimicrobial formulations that aid in wound healing
04/19/2012WO2012050923A2 Engineered polypeptides having enhanced duration of action
04/19/2012WO2012050896A2 Protease selective supramolecular assemblies
04/19/2012WO2012050810A2 Shape-controlled magnetic nanoparticles as t1 contrast agents for magnetic resonance imaging
04/19/2012WO2012050359A2 Hydrogel particle coated with lipid and method for manufacturing same
04/19/2012WO2012050193A1 Ebola virus liposome vaccine
04/19/2012WO2012050184A1 Sustained-release pharmaceutical composition
04/19/2012WO2012049624A1 Pretargeting kit, method and agents used therein
04/19/2012WO2012049545A1 A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer and a process to make it
04/19/2012WO2012049544A1 A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, a hydrocortisone acetate as a corticosteroid, and clotrimazole as an antifungal agent, and a process to make it
04/19/2012WO2012049543A1 A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer and a corticosteroid, and a process to make it
04/19/2012WO2012049542A1 A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, mometasone as a corticosteroid and clotrimazol as antifungal agent, and a process to make it
04/19/2012WO2012049541A1 A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer and a corticosteroid, and a process to make it
04/19/2012WO2012049338A1 Dendrimers based on pamam derivatized with alkyl sulfonyl groups
04/19/2012WO2012049324A2 New emd formulation comprising pga
04/19/2012WO2012049159A1 Composition for treating cancer by the controlled release of an active substance
04/19/2012WO2012048854A2 Formulation suitable for stabilizing proteins, which is free of mammalian excipients
04/19/2012WO2012048653A1 Long-life interferon fusion protein and use thereof
04/19/2012WO2012014046A3 Supramolecular aggregates as drug carriers on cell expressing receptors for branched neurotensin
04/19/2012WO2012013742A3 Stabilization of fsh
04/19/2012WO2011163123A3 Remover in a container
04/19/2012WO2011159871A3 Compositions and methods for the treatment of addiction, psychiatric disorders, and neurodegenerative disease
04/19/2012WO2011155800A3 Deacetylation hydrolase of hyaluronic acid, hyaluronic acid deacetylated by same and derivative thereof
04/19/2012WO2011152689A3 Method for purifying fucoxanthin derived from seaweed
04/19/2012WO2011150418A3 Compositions and methods for treating pathologies
04/19/2012WO2011150229A3 Dietary supplements containing extracts of cinnamon and methods of using same to promote enhanced sirtuin, cell and telomere integrity
04/19/2012WO2011150127A3 Novel systems, vectors, and methods for delivery of biomolecules to eukaryotic cells
04/19/2012WO2011146518A9 Pegylated c-peptide
04/19/2012WO2011144674A3 PHARMACEUTICAL FORMULATION COMPRISING INSULIN GLARGINE AND SBE4-ß-CYD
04/19/2012WO2011137354A3 Delivery proteins
04/19/2012WO2011133566A3 Repairing bruch's membrane with hydrogels
04/19/2012WO2011128783A3 Stable liquid oily ready-to-use formulations, preparation thereof and use thereof
04/19/2012WO2011098285A3 Dermatological, pharmaceutical composition suitable for oligonucleotides
04/19/2012WO2011091205A3 Intracameral sustained release therapeutic agent implants
04/19/2012WO2011073234A3 Dry growth hormone composition transiently linked to a polymer carrier
04/19/2012WO2011031621A8 High strength seamless alginate capsules
04/19/2012US20120095518 Bone cement formula and bioresorbable hardened bone cement composites prepared with the same
04/19/2012US20120095390 Generation of Therapeutic Microfoam
04/19/2012US20120095386 Composition and device structure for iontophoresis
04/19/2012US20120095235 Thioflavin derivates for use in the antemortem diagnosis of alzheimer's disease and in vivo imaging and prevention of amyloid deposition
04/19/2012US20120095115 Ester Mixtures And Compositions Comprising Such Ester Mixtures
04/19/2012US20120095114 Functionalized biodegradable triclosan monomers and oligomers for controlled release
04/19/2012US20120095112 Branched polymer dispersants
04/19/2012US20120095111 Branched polymer dispersants
04/19/2012US20120095110 Branched polymer dispersants
04/19/2012US20120095109 Film Forming, Silicone Containing Compositions
04/19/2012US20120095090 Novel composition and method for stabilizing the same
04/19/2012US20120095075 Novel lipids and compositions for the delivery of therapeutics